{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:05:29Z","timestamp":1759341929644},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.neurol.2009.09.006","type":"journal-article","created":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T04:20:42Z","timestamp":1255666842000},"page":"400-405","source":"Crossref","is-referenced-by-count":1,"title":["Traitement de la myasth\u00e9nie auto-immune"],"prefix":"10.1016","volume":"166","author":[{"given":"I.","family":"P\u00e9nisson-Besnier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neurol.2009.09.006_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005081.pub2","article-title":"Medical and surgical treatment for ocular myasthenia","author":"Benatar","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2009.09.006_bib2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1212\/01.wnl.0000324254.97372.e0","article-title":"The muddle of micophenolate mofetil in myasthenia","volume":"71","author":"Benatar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.09.006_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s004150050059","article-title":"Myasthenia gravis: diagnosis and follow-up of 100\u00a0consecutive patients","volume":"244","author":"Beekman","year":"1997","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2009.09.006_bib4","first-page":"301","article-title":"Etiology, mechanisms and anesthesia implications of auto immune myasthenia gravis","volume":"70","author":"Ceremuga","year":"2002","journal-title":"AANA J"},{"key":"10.1016\/j.neurol.2009.09.006_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mus.10133","article-title":"Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis","volume":"26","author":"De Feo","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2009.09.006_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1405.012","article-title":"Response to therapy in myasthenia gravis with anti-MuSK antibodies","volume":"1132","author":"Evoli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2009.09.006_bib7","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1586\/14737175.8.6.979","article-title":"Myasthenia gravis during pregnancy","volume":"8","author":"Ferrero","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.neurol.2009.09.006_bib8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high dose intravenous immunoglobulin in myasthenia gravis","volume":"48","author":"Gajdos","year":"1997","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2009.09.006_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002277.pub3","article-title":"Intravenous immunoglobulin for myasthenia gravis","author":"Gajdos","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2009.09.006_bib10","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/archneur.62.11.1689","article-title":"Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial","volume":"62","author":"Gajdos","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2009.09.006_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ajh.20169","article-title":"Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma","volume":"77","author":"Gajra","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.neurol.2009.09.006_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.nurt.2008.08.011","article-title":"Current and future standards in treatment of myasthenia gravis","volume":"5","author":"Gold","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurol.2009.09.006_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.09.006_bib14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/mus.20479","article-title":"Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab","volume":"33","author":"Hain","year":"2006","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.neurol.2009.09.006_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005224.pub2","article-title":"Immunosuppressive agents for myasthenia gravis","author":"Hart","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2009.09.006_bib16","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.wnl.0000183145.91579.74","article-title":"Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG","volume":"65","author":"Hatanaka","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.09.006_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002826-200105000-00010","article-title":"The use of intravenous immunoglobulin as maintenance therapy in myasthenia gravis","volume":"24","author":"Hilkevich","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neurol.2009.09.006_bib18","first-page":"201","article-title":"Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients","author":"Illa","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2009.09.006_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis. Recommendations for clinical research standards","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.09.006_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.nrl.0000051446.03160.2e","article-title":"Thymectomy for myasthenia gravis: analysis of controversies-patient management","volume":"9","author":"Jaretzki","year":"2003","journal-title":"Neurologist"},{"key":"10.1016\/j.neurol.2009.09.006_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1749-6632.1987.tb51325.x","article-title":"Long-term corticosteroid treatment of myasthenia gravis","volume":"505","author":"Johns","year":"1987","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurol.2009.09.006_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-2004-829595","article-title":"Myasthenia gravis: management of myasthenic crisis and perioperative care","volume":"24","author":"Juel","year":"2004","journal-title":"Semin Neurol"},{"key":"10.1016\/j.neurol.2009.09.006_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1172-2-44","article-title":"Myasthenia gravis","volume":"2","author":"Juel","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurol.2009.09.006_bib24","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/jnnp.2004.052415","article-title":"The features of myasthenia gravis with autoantibodies to MuSK","volume":"76","author":"Lavrnic","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.09.006_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1749-6632.1981.tb33767.x","article-title":"Effect of immunosuppressive drugs (azathioprine)","volume":"377","author":"Mertens","year":"1981","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.neurol.2009.09.006_bib26","doi-asserted-by":"crossref","unstructured":"Muscle Study Group. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. Neurology 2008;71:394-9.","DOI":"10.1212\/01.wnl.0000312373.67493.7f"},{"key":"10.1016\/j.neurol.2009.09.006_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000085833","article-title":"Efficacy of low-dose FK506\u00a0in the treatment of Myasthenia gravis\u00a0\u2013\u00a0a randomized pilot study","volume":"53","author":"Nagane","year":"2005","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neurol.2009.09.006_bib28","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"Myasthenia Gravis Study Group. A randomized, double-blind trial of prednisolone alone or with azathioprine in Myasthenia Gravis","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.09.006_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.410150316","article-title":"Long-term corticosteroid treatment of myasthenia gravis: report of 116\u00a0patients","volume":"15","author":"Pascuzzi","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2009.09.006_bib30","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","article-title":"Treatment of autoimmune myasthenia gravis","volume":"61","author":"Richman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.09.006_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0733-8619(18)30101-4","article-title":"The treatment of patients with myasthenia gravis","volume":"12","author":"Sanders","year":"1994","journal-title":"Neurol Clin"},{"key":"10.1016\/j.neurol.2009.09.006_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","article-title":"An international, phase\u00a0III, randomized trial of mycophenolate mofetil in myasthenia gravis","volume":"71","author":"Sanders","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2009.09.006_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002828.pub2","article-title":"Corticosteroids for myasthenia gravis","author":"Schneider-Gold","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2009.09.006_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM197401102900204","article-title":"Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment","volume":"290","author":"Seybold","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2009.09.006_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1196\/annals.1405.022","article-title":"Antisense treatment for myasthenia gravis: experience with monarsen","volume":"1132","author":"Sussman","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurol.2009.09.006_bib36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198703193161205","article-title":"Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis","volume":"316","author":"Tindall","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2009.09.006_bib37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1749-6632.1993.tb22937.x","article-title":"A clinical therapeutic trial of cyclosporine in myasthenia gravis","volume":"681","author":"Tindall","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2009.09.006_bib38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1212\/01.wnl.0000173031.56429.04","article-title":"Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil","volume":"65","author":"Vernino","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.09.006_bib39","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(00)94294-6","article-title":"Treatment of myasthenia gravis with physostigmine","volume":"1","author":"Walker","year":"1934","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2009.09.006_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0303-8467(02)00017-3","article-title":"Intravenous immunoglobulin monotherapy in long-term treatment of myasthenia gravis","volume":"105","author":"Wegner","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.neurol.2009.09.006_bib41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ana.410150615","article-title":"Azathioprine in the treatment of myasthenia gravis","volume":"15","author":"Witte","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2009.09.006_bib42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1067\/S0022-3476(03)00300-7","article-title":"Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report","volume":"143","author":"Wylam","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.neurol.2009.09.006_bib43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/01.wnl.0000256698.69121.45","article-title":"IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial","volume":"68","author":"Zinman","year":"2007","journal-title":"Neurology"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378709004512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378709004512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T01:40:29Z","timestamp":1558575629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378709004512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0035378709004512"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2009.09.006","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}